French firms partner on biocatalysis

- Last updated on GMT

LibraGen, a company specialising in the development of new enzymes
to improve manufacturing processes in the pharmaceutical and
chemical industries, has teamed up with fellow French firm Synkem.

The two firms have entered a non-exclusive agreement to co-market their products and outsourcing services to customers, and will also collaborate on the development of new projects.

LibraGen has developed a platform that allows it to discover new enzymes from metabolic pathways that are not exploited by the industry at present. Synkem​, which specialises in supplying active pharmaceutical ingredients (APIs), will contribute its expertise in process research and Good Manufacturing Practice (GMP) production.

"By entering this partnership, LibraGen will gain access to a wider number of customers"​ for its biocatalysts, said Renaud Nalin, LibraGen​'s CEO.

Related news

Related products

TCC TB – a new filler for direct compression

TCC TB – a new filler for direct compression

Jungbunzlauer | 09-Oct-2017 | Technical / White Paper

TCC TB is a tricalcium citrate tetrahydrate designed to function as a direct compression excipient. It combines exceptional compression characteristics,...

Steridose

Optimizing vessel geometry for mag drive agitators

Steridose, Inc | 14-Sep-2017 | Technical / White Paper

The performance of a bottom mount magnetically driven agitator (mag drive mixer) is heavily dependent on its relationship with the vessel’s geometry, baffles,...

Related suppliers